Patients Can't Wait

  • The scientific advances in cell therapy are significant and hold promise for those suffering from a multitude of conditions, including Alzheimer’s disease, cancer, and diabetes.

  • The U.S. lacks both the regulatory tools and the incentives to promote the advancement of cell therapies for Americans.

  • Patients can’t wait – Congress should support and pass the REGROW Act (S. 2689 / H.R. 4762) to bring regenerative cell therapies to the United States.